Agreement and medical tests completed, paperworks sign as Chelsea set to announce another January signing

 Chelsea have made the surprising decision to not make any signings in January. But it appears that the Blues have finally been able to finalise the future of striker Armando Broja heading into the final hours of deadline day (February 1).


Agreement and medical tests completed, paperworks sign as Chelsea set to announce another January signing


Chelsea Agree Armando Broja Loan Move to Fulham

What Are Fulham Offering for Broja?

 

Fabrizio Romano has given his ‘Here We Go’ to confirm that Fulham have finally reached an agreement with Chelsea for the loan transfer of the Albanian forward until the end of the 2023/24 season. He also claims that the Cottagers have agreed to pay a loan fee of £4 million for this signing, but there is no mention of whether or not an option or obligatory buy clause is a part of the deal.

The journalist states that Broja “will complete medical tests tonight” to officially sign with Fulham in time to be registered as their new player before the window shuts. This seems to end the speculation over the future of the Chelsea striker, with the Blues having also reportedly rejected a loan offer from Wolves before deciding to send him out on a short-term move to their fellow London side.

Chelsea’s Winter Transfer Business Summarized

Chelsea have gained a reputation for being high-spenders ever since Todd Boehly and Clearwater Capital Group took over as their owners. But they have stunned many by not signing a single player in the winter window.

Mauricio Pochettino’s side appears ready to send another player out on loan for the rest of the season to gain more playing time and develop their skills. Broja, who was praised as a player with “amazing” potential by the Chelsea manager earlier this season, will be keen on proving himself as a consistent goal-scorer after only being able to score two goals and provide as many assists in 19 appearances in all competitions this seas

Post a Comment

0 Comments